Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Annual review of nutrition

• Publication date

  2017-08-21

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1146/annurev-nutr-071816-064732PMID 28715991
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Archaebiotics Proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease

  2019cited by this paper
• Dietary choline and betaine; associations with subclinical markers of cardiovascular disease risk and incidence of CVD, coronary heart disease and stroke: the Jackson Heart Study

  2018cited by this paper
• Intra-individual variation of plasma trimethylamine-N-oxide (TMAO), betaine and choline over 1 year

  2017cited by this paper
• Single-Subject Studies in Translational Nutrition Research.

  2017cited by this paper
• Dietary Fat and Risk of Cardiovascular Disease: Recent Controversies and Advances.

  2017cited by this paper
• Trimethylamine‐N‐oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial

  2017influential reference
• Immune-Suppressing Cellular Elements of the Tumor Microenvironment

  2017cited by this paper
• Dietary phosphatidylcholine and risk of all-cause and cardiovascular-specific mortality among US women and men.

  2016cited by this paper
• Microbiota-Dependent Marker TMAO Is Elevated in Silent Ischemia but Is Not Associated With First-Time Myocardial Infarction in HIV Infection

  2016cited by this paper
• Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery

  2016cited by this paper
• Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden.

  2016cited by this paper
• The gut microbiome, diet, and links to cardiometabolic and chronic disorders

  2016cited by this paper
• Intestinal Microbiota‐Generated Metabolite Trimethylamine‐N‐Oxide and 5‐Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE‐Like Patient Cohort

  2016cited by this paper
• Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota

  2016cited by this paper
• L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE(-/-) transgenic mice expressing CETP.

  2016cited by this paper
• Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.

  2016cited by this paper
• Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels

  2016cited by this paper
• Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association

  2016cited by this paper
• Plasma Concentrations of Trimethylamine-N-oxide Are Directly Associated with Dairy Food Consumption and Low-Grade Inflammation in a German Adult Population.

  2016cited by this paper
• Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.

  2016cited by this paper
• Microbiota‐Dependent Metabolite Trimethylamine N‐Oxide and Coronary Artery Calcium in the Coronary Artery Risk Development in Young Adults Study (CARDIA)

  2016cited by this paper
• Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease

  2016cited by this paper
• Trimethylamine N-Oxide as a Novel Therapeutic Target in CKD.

  2016cited by this paper
• Risk Prediction in CKD: The Rational Alignment of Health Care Resources in CKD 4/5 Care.

  2016cited by this paper
• Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.

  2016cited by this paper
• Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine.

  2016cited by this paper
• Trimethylamine N‐Oxide Promotes Vascular Inflammation Through Signaling of Mitogen‐Activated Protein Kinase and Nuclear Factor‐κB

  2016cited by this paper
• Choline Diet and Its Gut Microbe–Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload–Induced Heart Failure

  2016cited by this paper
• Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.

  2016cited by this paper
• Rational design of apolipoprotein E mimetic peptides

  2016cited by this paper
• Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis[S]

  2015cited by this paper
• Targeted plasma metabolome response to variations in dietary glycemic load in a randomized, controlled, crossover feeding trial in healthy adults.

  2015cited by this paper
• Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide

  2015influential reference
• Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease

  2015influential reference
• Egg Phospholipids and Cardiovascular Health

  2015cited by this paper
• Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.

  2015cited by this paper
• The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance.

  2015cited by this paper
• Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.

  2015influential reference
• Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.

  2015cited by this paper
• A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat

  2015cited by this paper
• Microbiology Meets Big Data: The Case of Gut Microbiota-Derived Trimethylamine.

  2015influential reference
• Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study

  2015cited by this paper
• The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases.

  2015influential reference
• Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis

  2015influential reference
• Emerging roles of flavin monooxygenase 3 in cholesterol metabolism and atherosclerosis

  2015cited by this paper
• Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure

  2015cited by this paper
• Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha‐tocopherol, beta‐carotene cancer prevention (ATBC) study

  2015cited by this paper
• Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.

  2015cited by this paper
• Rapid LC‐MRM‐MS assay for simultaneous quantification of choline, betaine, trimethylamine, trimethylamine N‐oxide, and creatinine in human plasma and urine

  2015cited by this paper
• Mechanism of Prominent Trimethylamine Oxide (TMAO) Accumulation in Hemodialysis Patients

  2015cited by this paper
• Oral L-Carnitine Supplementation Increases Trimethylamine-N-oxide but Reduces Markers of Vascular Injury in Hemodialysis Patients

  2015cited by this paper
• Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.

  2015cited by this paper
• The Relationship Between Trimethylamine-N-Oxide and Prevalent Cardiovascular Disease in a Multiethnic Population Living in Canada.

  2015cited by this paper
• Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study.

  2014cited by this paper
• Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study

  2014cited by this paper
• Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota

  2014cited by this paper
• Comparative Genome-Wide Association Studies in Mice and Humans for Trimethylamine N-Oxide, a Proatherogenic Metabolite of Choline and L-Carnitine

  2014cited by this paper
• Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.

  2014influential reference
• Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet.

  2014cited by this paper
• Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.

  2014cited by this paper
• Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease.

  2014influential reference
• Plasma choline metabolites and colorectal cancer risk in the Women's Health Initiative Observational Study.

  2014cited by this paper
• γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO.

  2014cited by this paper
• Metaorganismal nutrient metabolism as a basis of cardiovascular disease

  2014cited by this paper
• Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation.

  2013cited by this paper
• Supplemental materials for: Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

  2013influential reference
• L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis.

  2013cited by this paper
• A combined epidemiologic and metabolomic approach improves CKD prediction.

  2013cited by this paper
• Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.

  2013influential reference
• Human Trace Amine-Associated Receptor TAAR5 Can Be Activated by Trimethylamine

  2013influential reference
• Meat consumption and mortality - results from the European Prospective Investigation into Cancer and Nutrition

  2013cited by this paper
• Meldonium decreases the diet‐increased plasma levels of trimethylamine N‐oxide, a metabolite associated with atherosclerosis

  2013influential reference
• Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis

  2012cited by this paper
• Genome Sequence of “Candidatus Methanomethylophilus alvus” Mx1201, a Methanogenic Archaeon from the Human Gut Belonging to a Seventh Order of Methanogens

  2012cited by this paper
• Methanomassiliicoccus luminyensis gen. nov., sp. nov., a methanogenic archaeon isolated from human faeces.

  2012cited by this paper
• Serum metabolic variables associated with impaired glucose tolerance induced by high-fat-high-cholesterol diet in Macaca mulatta

  2012cited by this paper
• Converging on a mechanism for choline degradation

  2012cited by this paper
• Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme

  2012cited by this paper
• Entropic stabilization of proteins by TMAO.

  2011cited by this paper
• Trimethylaminuria: causes and diagnosis of a socially distressing condition.

  2011influential reference
• Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

  2011influential reference
• Role of carnitine in disease

  2010cited by this paper
• Toxicometabolomics of Urinary Biomarkers for Human Gastric Cancer in a Mouse Model

  2010cited by this paper
• Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride.

  2009cited by this paper
• Metabonomics studies of intact hepatic and renal cortical tissues from diabetic db/db mice using high-resolution magic-angle spinning 1H NMR spectroscopy

  2009cited by this paper
• Fish consumption and risk of sudden cardiac death.

  2009cited by this paper
• Probiotic modulation of symbiotic gut microbial–host metabolic interactions in a humanized microbiome mouse model

  2008cited by this paper
• Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.

  2008cited by this paper
• A flow injection electrospray ionization tandem mass spectrometric method for the simultaneous measurement of trimethylamine and trimethylamine N-oxide in urine.

  2008cited by this paper
• Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women

  2008cited by this paper
• Structure and interaction in aqueous urea-trimethylamine-N-oxide solutions.

  2007cited by this paper
• Effect of molecular crowding on the enzymes of glycogenolysis

  2007cited by this paper
• heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

  2007cited by this paper
• Rapid screening assay of trimethylaminuria in urine with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

  2007cited by this paper
• Transient trimethylaminuria related to menstruation

  2007cited by this paper
• Choline: critical role during fetal development and dietary requirements in adults.

  2006cited by this paper
• Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice

  2006cited by this paper
• QUANTITATIVE ANALYSIS OF FMO GENE mRNA LEVELS IN HUMAN TISSUES

  2006cited by this paper
• Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis.

  2006cited by this paper
• A molecular mechanism for osmolyte-induced protein stability

  2006cited by this paper

• Mechanistic and hormetic insights into the interaction between dietary bioactive compounds and gut microbiota in modulating human health

  2026cites this paper
• Endometrial stromal cell-derived TMAO sustains decidualization to prevent recurrent spontaneous abortion.

  2026cites this paper
• Anthocyanins and Metabolic Disease: A New Frontier in Precision Nutrition

  2026cites this paper
• Nutrition and the gut microbiome: a symbiotic dialogue influencing health and disease.

  2026cites this paper
• Exercise-mimicking effects of betaine in chronic disease prevention and management

  2026cites this paper
• Establishment of a mouse model of TMAO‐induced cardiac injury and application of MICT intervention

  2026cites this paper
• Exogenous Trimethylamine N-Oxide (TMAO) Improves Apple Rootstock Drought Tolerance Through Physiological Modulation

  2026cites this paper
• Characteristics of Infections in Hemodialysis Patients: Results from a Single-Center 29-Month Observational Cohort Study from Romania

  2026cites this paper
• Plasma trimethylamine-N-oxide quantification in patients with Hashimoto's thyroiditis by using LC-MS/MS.

  2025cites this paper
• Effects of choline metabolite—trimethylamine N-oxide on immunometabolism in inflammatory bowel disease

  2025cites this paper
• The gut-heart axis: unveiling the roles of gut microbiota in cardiovascular diseases

  2025cites this paper
• Assessing Choline, Carnitine, and Betaine Intake and Their Effects on Trimethylamine N-Oxide Levels: Validation of a Dietary Questionnaire in a Central European Population

  2025cites this paper
• Integrative Perspectives on Myocardial Infarction Risk and Ischemic stroke: The Interplay Between Microbiota, Metabolism, and Epigenetics

  2025cites this paper
• How the Microbiome Affects Canine Health

  2025influential citation
• Histidine betaine trimethylammonia-lyase, a novel enzyme coupled with terminal urocanate reductase in Shewanella woodyi grown anaerobically

  2025cites this paper
• Post-stroke Arrhythmias: Performance of Brain-heart Crosstalk Networks.

  2025cites this paper
• Methylamine metabolites and progression to kidney failure in type 2 diabetes: an Asian and European prospective study.

  2025cites this paper
• Advancements in the investigation of gut microbiota-based strategies for stroke prevention and treatment

  2025cites this paper
• Development and Validation of a Simple and Cost-Effective LC-MS/MS Method for the Quantitation of the Gut-Derived Metabolite Trimethylamine N-Oxide in Human Plasma of Healthy and Hyperlipidemic Volunteers

  2025cites this paper
• Independent Predictors of Circulating Trimethylamine N-Oxide (TMAO) and Resistin Levels in Subjects with Obesity: Associations with Carotid Intima-Media Thickness and Metabolic Parameters

  2025cites this paper
• Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies

  2025cites this paper
• The Relationship between Human Microbial Community Imbalance and Aging and Its Research Progress

  2025cites this paper
• Do we Have the Gut to Beat Thrombosis?

  2025cites this paper
• TMAO and the gut microbiome: implications for the CVD-CKD-IBD axis

  2025cites this paper
• Contribution of dietary methionine to gut health and its related diseases: implications for precision nutrition

  2025cites this paper
• Fecal microbiota transplantation is a promising therapy for kidney diseases

  2025cites this paper
• Alterations in gut–kidney axis indicators and TMAO-related biomarkers in elderly patients with hypertensive nephropathy

  2025cites this paper
• Lifelong TMAO exposure exerts hypotensive effects in aged spontaneously hypertensive rats

  2025cites this paper
• Trimethylamine N-Oxide (TMAO) and cancer risk: Insights into a possible link.

  2025cites this paper
• Dietary Fatty Acids Modulate Gut Microbiota-Derived Trimethylamine-N-Oxide: Potential Mechanisms and Future Perspective

  2025cites this paper
• Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy

  2025cites this paper
• Influence of dietary protein and fiber intake interactions on the human gut microbiota composition and function: a systematic review and network meta-analysis of randomized controlled trials

  2025cites this paper
• Biosensors for probing trimethylamine and trimethylamine N-oxide: State-of-the-art

  2025cites this paper
• Pixel array-based urine biosensor for detection of trimethylamine N-oxide and glucose for early detection of diabetic kidney disease.

  2025cites this paper
• Fungal DNA in Circulation: A Sleuth's Clue to Predict Cardiovascular Risk for Hemodialysis Patients.

  2025cites this paper
• Future Directions in Choline: From Neurodevelopment to Cardiometabolic Health

  2025cites this paper
• Interventional approaches to combat obesity: Exploring the metabolomic signature of weight loss trials

  2025cites this paper
• Effects of Long-Term Airport Noise Exposure on Inflammation and Intestinal Flora and Their Metabolites in Mice

  2025cites this paper
• The Roles and Functions of Ergothioneine in Metabolic Diseases.

  2025cites this paper
• Comparison of short-term and long-term effects of peroral L-carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications

  2025cites this paper
• Correlation Analysis of Gut Microbiota Derivatives with Coronary Artery Disease Severity and Prognosis

  2025cites this paper
• The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis

  2025cites this paper
• Chemiluminescent Quantification of Trimethylamine Oxide in Seafoods

  2025cites this paper
• Bidirectional Association of Gut Microbiota-Derived Trimethylamine N-Oxide and its Precursors with Estimated Glomerular Filtration Rate: A Cross-Lagged Cohort Study.

  2025cites this paper
• Decoding TMAO in the Gut-Organ Axis: From Biomarkers and Cell Death Mechanisms to Therapeutic Horizons

  2025cites this paper
• Microvascular endothelial dysfunction in vascular senescence and disease

  2025cites this paper
• Machine learning-based early screening of mild cognitive impairment using nutrition-related biomarkers and functional indicators

  2025cites this paper
• Can Dietary Supplements Support Muscle Function and Physical Activity? A Narrative Review

  2025cites this paper
• Interaction studies unveil potential binding sites on bovine serum albumin for gut metabolite trimethylamine n-oxide (TMAO)

  2025cites this paper
• High Protein Diet Contributes to Insulin Resistance in Mice via Shaping Gut Microbiota

  2025cites this paper
• Sex-differences in endotoxemia and trimethylamine N-oxide according to the diet and type 2 diabetes status in coronary heart disease patients: from the CORDIOPREV study

  2025cites this paper
• A Pomegranate Polyphenol Extract Suppresses the Microbial Production of Proatherogenic Trimethylamine (TMA) in an In Vitro Human Colon Model

  2025cites this paper
• Association Between Gut Microbiome Alterations and Hypertension-Related Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

  2025cites this paper
• Host-microbe co-metabolism system as potential targets: the promising way for natural medicine to treat atherosclerosis.

  2025cites this paper
• Partial replacement of corn silage with sorghum-sudangrass silage improves growth performance and rumen function in Hu sheep via microbial and metabolic modulation

  2025cites this paper
• The role of trimethylamine N-oxide in disease pathogenesis and the therapeutic potential of traditional Chinese medicine

  2025cites this paper
• Landscape of Berberine Targets: A Potential Pharmacological Insight for Heart failure Treatment.

  2025cites this paper
• Advances in Acute Myocardial Infarction (AMI) Diagnostics: Classical Biomarkers, Emerging Tools, and the Rise of Non-Invasive Sampling

  2025cites this paper
• The Association Between Lifestyle Interventions and Trimethylamine N-Oxide: A Systematic-Narrative Hybrid Literature Review

  2025cites this paper
• Trimethylamine N-oxide detection for early prediction of renal function utilizing a three-dimensional localized electronic structure (3DLES) biosensor

  2025cites this paper
• Choline-Mediated Regulation of Follicular Growth: Interplay Between Steroid Synthesis, Epigenetics, and Oocyte Development

  2025cites this paper
• The Protective Mechanism of Moderate Intensity Continuous Training on TMAO-Induced Myocardial Injury Based on NMR Metabolomics

  2025cites this paper
• The Role of Intestinal Microbiota and Dietary Fibre in the Regulation of Blood Pressure Through the Interaction with Sodium: A Narrative Review

  2025cites this paper
• Mechanisms and intervention strategies of TMAO (Trimethylamine NOxide) in abdominal aortic aneurysm.

  2025cites this paper
• Implications of the microbiome and metabolic intermediaries produced by bacteria in breast cancer

  2024influential citation
• Human Gut Microbiota in Cardiovascular Disease.

  2024cites this paper
• TMAO Impairs Mouse Aortic Vasodilation by Inhibiting TRPV4 Channels in Endothelial Cells

  2024cites this paper
• The metabolic and endocrine impact of diet-derived gut microbiota metabolites on ageing and longevity.

  2024cites this paper
• Exploring the gut microbiome: probiotics, prebiotics, synbiotics, and postbiotics as key players in human health and disease improvement

  2024cites this paper
• Gut Microbiota and Its Metabolites: The Emerging Bridge Between Coronary Artery Disease and Anxiety and Depression?

  2024cites this paper
• Evaluation of Trimethylamine N-Oxide (TMAO) Levels in Blunt Thoracic Trauma: An Experimental Study

  2024cites this paper
• The human microbiome in space: parallels between Earth-based dysbiosis, implications for long-duration spaceflight, and possible mitigation strategies

  2024cites this paper
• Metabolic Profiling of Rat Kidney Tissue Following Administration of D-Allulose

  2024cites this paper
• Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases.

  2024cites this paper
• The mechanisms underlying acute myocardial infarction in chronic kidney disease patients undergoing hemodialysis.

  2024cites this paper
• Research Progress on the Correlation Between Hypertension and Gut Microbiota

  2024cites this paper
• Dynamic Changes in Gut Microbiota-Derived Metabolite Trimethylamine-N-Oxide and Risk of Type 2 Diabetes Mellitus: Potential for Dietary Changes in Diabetes Prevention

  2024cites this paper
• The Gut Microbial Metabolite Trimethylamine N-oxide, Incident CKD, and Kidney Function Decline

  2024cites this paper
• Choline in pregnant women: a systematic review and meta-analysis.

  2024cites this paper
• The role of FMO3 in metabolic diseases

  2024cites this paper
• The interaction between oral microbiota and gut microbiota in atherosclerosis

  2024cites this paper
• Gut Microbiota Metabolite TMA May Mediate the Effects of TMAO on Glucose and Lipid Metabolism in C57BL/6J Mice.

  2024cites this paper
• Therapeutic strategies to modulate gut microbial health: Approaches for sarcopenia management.

  2024cites this paper
• Pharmacological Activities, Therapeutic Effects, and Mechanistic Actions of Trigonelline

  2024cites this paper
• Shotgun metagenomics and systemic targeted metabolomics highlight indole-3-propionic acid as a protective gut microbial metabolite against influenza infection

  2024cites this paper
• Folic acid supplementation and serum trimethylamine oxide (TMAO) lowering: new insight from the post hoc analysis of Precision Folic Acid Trial to lower homocysteine (PFAT-Hcy)

  2024cites this paper
• Discovery of a Novel Bioactive Compound in Orange Peel Polar Fraction on the Inhibition of Trimethylamine and Trimethylamine N-Oxide through Metabolomics Approaches and In Vitro and In Vivo Assays: Feruloylputrescine Inhibits Trimethylamine via Suppressing cntA/B Enzyme.

  2024cites this paper
• Association of serum trimethylamine N-oxide levels and bone mineral density in type 2 diabetes mellitus

  2024cites this paper
• Research progress on the association between TMAO and vascular calcification in patients with chronic kidney disease

  2024cites this paper
• Association between plasma trimethylamine N-oxide and cerebral white matter hyperintensity: a cross-sectional study

  2024cites this paper
• Berries vs. Disease: Revenge of the Phytochemicals

  2024cites this paper
• Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder

  2024cites this paper
• Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling

  2024cites this paper
• Association between monosodium glutamate consumption with changes in gut microbiota and related metabolic dysbiosis—A systematic review

  2024cites this paper
• Association between trimethylamine N-oxide and prognosis of patients with myocardial infarction: a meta-analysis

  2024cites this paper
• Microbiome-Derived Trimethylamine N-Oxide (TMAO) as a Multifaceted Biomarker in Cardiovascular Disease: Challenges and Opportunities

  2024cites this paper
• Effect of anthocyanins on metabolic syndrome through interacting with gut microbiota.

  2024cites this paper
• Exploring Trimethylaminuria: Genetics and Molecular Mechanisms, Epidemiology, and Emerging Therapeutic Strategies

  2024cites this paper
• The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence

  2024cites this paper
• Polyphenols from hickory nut reduce the occurrence of atherosclerosis in mice by improving intestinal microbiota and inhibiting trimethylamine N-oxide production.

  2024cites this paper